Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice

Joshua Yang, Jiahong Sun, Demi M. Castellanos, William M. Pardridge, Rachita K. Sumbria

Open source

DOI
10.1021/acs.molpharmaceut.0c00231
Published
2020-06-24
Container
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.0c00231,
  title = {Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice},
  author = {Joshua Yang and Jiahong Sun and Demi M. Castellanos and William M. Pardridge and Rachita K. Sumbria},
  year = {2020},
  journal = {Molecular Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.0c00231},
  url = {https://doi.org/10.1021/acs.molpharmaceut.0c00231}
}

RIS

TY  - JOUR
TI  - Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice
AU  - Joshua Yang
AU  - Jiahong Sun
AU  - Demi M. Castellanos
AU  - William M. Pardridge
AU  - Rachita K. Sumbria
PY  - 2020
JO  - Molecular Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.0c00231
UR  - https://doi.org/10.1021/acs.molpharmaceut.0c00231
ER  - 

APA

Yang, J., Sun, J., Castellanos, D. M., Pardridge, W. M., & Sumbria, R. K. (2020). Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.0c00231

Source records